Theravance Biopharma Inc

Company Snapshot
Ugland House, South Church Street
Grand Cayman, KY1-1104
Cayman Islands
Sector: Healthcare
Industry: Biotechnology
Full Time Employees: 111
Please select from the dropdown
Company Financials

2020
2021
2022
Gross Profit
$71,857,000
Operating Income
($297,757,000)
($246,004,000)
($86,117,000)
Net Income
($278,017,000)
($199,426,000)
$872,132,000
2020
Gross Profit
$71,857,000
Operating Income
($297,757,000)
Net Income
($278,017,000)
2021
Gross Profit
Operating Income
($246,004,000)
Net Income
($199,426,000)
2022
Gross Profit
Operating Income
($86,117,000)
Net Income
$872,132,000
The above data on Theravance Biopharma Inc came from annual proxy statements to the SEC. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov
Top Executives
Total Cash info
Equity info
Other info
Total Compensation
Top Executives
Total Compensation
Chief Executive Officer and Chairman of the Board
$1,770,161
$4,497,647
$5,099
$6,272,907
$6,272,907
Chief Executive Officer and Chairman of the Board
Senior Vice President Research and Development
$1,061,469
$0
$5,130
$1,066,599
$1,066,599
Senior Vice President Research and Development
Chief Business Officer and Senior Vice President Commercial and Medical Affairs
$937,707
$0
$5,099
$942,806
$942,806
Chief Business Officer and Senior Vice President Commercial and Medical Affairs
Independent Director
$89,500
$246,116
$0
$335,616
$335,616
Independent Director
Independent Director
$78,821
$246,116
$0
$324,937
Independent Director
Theravance Biopharma Inc listed the above executives on its annual proxy statement to the SEC for the fiscal year of 2022. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov

The sum of all cash payments made to an individual for services during a given year. It is comprised of yearly Base Pay and Bonuses

To view more detailed proxy data including previous years contact our sales team.

Contact Us

The value of stock and option awards plus long term incentives granted.

To view more detailed proxy data including previous years contact our sales team.

Contact Us

This covers all compensation that don't fit in any of these other standard categories

To view more detailed proxy data including previous years contact our sales team.

Contact Us